Amphiphilic glycomimetics encompassing a rigid, undistortable nor-tropane skeleton based on 1,6-anhydro-L-idonojirimycin and a polyfluorinated antenna, when formulated as the corresponding inclusion complexes with β-cyclodextrin (βCD), have been shown to behave as pharmacological chaperones (PCs) that efficiently rescue lysosomal β- glucocerebrosidase mutants associated to the neuronopathic variants of Gaucher disease (GD), including the highly refractory L444P/L444P and L444P/P415R single nucleotide polymorphs, in patient fibroblasts. The body of work here presented includes the design criteria for the PC prototype, the synthesis of a series of candidates, the characterization of the PC:βCD complexes, the determination of the selectivity p...
A molecular-diversity-oriented approach for the preparation of bicyclic sp2-iminosugar glycomimetics...
Gaucher disease (GD) is one of the most prevalent lysosomal storage diseases.A mutation on gene gba1...
A series of sp2-iminosugar glycomimetics differing in the reducing or nonreducing character, the con...
Amphiphilic glycomimetics encompassing a rigid, undistortable nor-tropane skeleton based on 1,6-anh...
A series of sp2-iminosugar glycomimetics differing in the reducing or nonreducing character, the con...
A series of sp2-iminosugar glycomimetics differing in the reducing or nonreducing character, the con...
Pyranoid-type glycomimetics having a cis-1,2-fused glucopyranose–2-alkylsulfanyl-1,3-oxazoline (Glc-...
Piperidine-based photoswitchable derivatives have been developed as putative pharmacological chapero...
Gaucher's disease, the most prevalent lysosomal storage disorder, is caused by missense mutation of ...
Introduction: Mutations in the gene encoding for acid β-glucosidase (β-glucocerebrosidase, GlcCerase...
Lysosomal storage disorders (LSDs) are often caused by mutations that destabilize native folding and...
Chaperone Mediated Therapy represents an innovative and strategic approach to treat lysosomal storag...
Gaucher disease is an autosomal recessive lysosomal storage disorder caused by the deficient activit...
GM1 gangliosidosis and Morquio B disease are autosomal recessive diseases caused by the defect in th...
The beta-glucocerebrosidase (GBA1) gene encodes the lysosomal beta-glucocerebrosidase (GCase) that m...
A molecular-diversity-oriented approach for the preparation of bicyclic sp2-iminosugar glycomimetics...
Gaucher disease (GD) is one of the most prevalent lysosomal storage diseases.A mutation on gene gba1...
A series of sp2-iminosugar glycomimetics differing in the reducing or nonreducing character, the con...
Amphiphilic glycomimetics encompassing a rigid, undistortable nor-tropane skeleton based on 1,6-anh...
A series of sp2-iminosugar glycomimetics differing in the reducing or nonreducing character, the con...
A series of sp2-iminosugar glycomimetics differing in the reducing or nonreducing character, the con...
Pyranoid-type glycomimetics having a cis-1,2-fused glucopyranose–2-alkylsulfanyl-1,3-oxazoline (Glc-...
Piperidine-based photoswitchable derivatives have been developed as putative pharmacological chapero...
Gaucher's disease, the most prevalent lysosomal storage disorder, is caused by missense mutation of ...
Introduction: Mutations in the gene encoding for acid β-glucosidase (β-glucocerebrosidase, GlcCerase...
Lysosomal storage disorders (LSDs) are often caused by mutations that destabilize native folding and...
Chaperone Mediated Therapy represents an innovative and strategic approach to treat lysosomal storag...
Gaucher disease is an autosomal recessive lysosomal storage disorder caused by the deficient activit...
GM1 gangliosidosis and Morquio B disease are autosomal recessive diseases caused by the defect in th...
The beta-glucocerebrosidase (GBA1) gene encodes the lysosomal beta-glucocerebrosidase (GCase) that m...
A molecular-diversity-oriented approach for the preparation of bicyclic sp2-iminosugar glycomimetics...
Gaucher disease (GD) is one of the most prevalent lysosomal storage diseases.A mutation on gene gba1...
A series of sp2-iminosugar glycomimetics differing in the reducing or nonreducing character, the con...